November 1 CBPP Spotlight | Case-Based Peer Perspectives Spotlight Live

CASPIAN Trial Results Offer Another Option for SCLC

November 29, 2020

Clinical Articles

The results from the phase 3 CASPIAN trial were reviewed and compared with the phase 3 IMpower133 by Jyoti D. Patel, MD, during a Targeted Oncology Case Based Peer Perspectives event.

New Therapies Provide Options in Metastatic Breast Cancer

November 28, 2020

Clinical Articles

Comparing the efficacy of selective HER2 kinase inhibitors in HER2-positive metastatic breast cancer, it was shown that tucatinib may have been approved in the second-line setting due to it's unique impact on the central nervous system. Another HER2 inhibitor, trastuzumab deruxtecan has demonstrated promise in a phase 2 study and is now being confirmed in a phase 3 study.

Exploring First-line Therapies in Peripheral T-Cell Lymphomas

November 23, 2020

Clinical Articles

During the Targeted Oncology Case Based Peer Perspectives event, Javier L. Munoz, MD, Hematologist/Oncologist Director, Lymphoma Program Mayo Clinic, discussed the case of 60-year-old patient with peripheral T-cell lymphoma.

Many Oncologists Favor Consolidation Immunotherapy Following Chemoradiation for Stage III NSCLC

November 21, 2020

Clinical Articles

During a Targeted Oncology Case Based Peer Perspectives event, John Heymach, MD, PhD, professor and Chair, David Bruton Jr Chair in Cancer Research. Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, discussed the guidelines and therapeutic option for stage III non–small cell lung cancer, based on a case of a 66-year-old patient.